Letter to the editor: Possible role of topical povidone iodine in case of accidental ocular exposure to SARS-CoV-2

[1]  A. Moreno,et al.  Characteristics of Ocular Findings of Patients with Coronavirus Disease , 2020, International Journal of Advanced Engineering Research and Science.

[2]  Xinghuai Sun,et al.  SARS-CoV-2 receptor ACE2 is expressed in human conjunctival tissue, especially in diseased conjunctival tissue , 2020, The Ocular Surface.

[3]  P. D. Dios,et al.  Is povidone iodine mouthwash effective against SARS-CoV-2? First in vivo tests. , 2020 .

[4]  J. Tong,et al.  Relapsing viral keratoconjunctivitis in COVID-19: a case report , 2020, Virology Journal.

[5]  J. Limeres Posse,et al.  Is povidone iodine mouthwash effective against SARS‐CoV‐2? First in vivo tests , 2020, Oral diseases.

[6]  A. Bidra,et al.  Comparison of In Vitro Inactivation of SARS CoV‐2 with Hydrogen Peroxide and Povidone‐Iodine Oral Antiseptic Rinses , 2020, Journal of prosthodontics : official journal of the American College of Prosthodontists.

[7]  M. Paranjape,et al.  Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic , 2020, American Journal of Otolaryngology.

[8]  E. Duh,et al.  ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection , 2020, The Ocular Surface.

[9]  A. Bidra,et al.  Rapid In‐Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) Using Povidone‐Iodine Oral Antiseptic Rinse , 2020, Journal of prosthodontics : official journal of the American College of Prosthodontists.

[10]  P. Conti,et al.  A new pharmacological approach based on remdesivir aerosolized administration on SARS-CoV-2 pulmonary inflammation: A possible and rational therapeutic application , 2020, Medical Hypotheses.

[11]  Q. Liu,et al.  COVID-19 receptor ACE2 is expressed in human conjunctival tissue, expecially in diseased conjunctival tissue , 2020, medRxiv.

[12]  G. Wei,et al.  In-Vivo Toxicity Studies and In-Vitro Inactivation of SARS-CoV-2 by Povidone-iodine In-situ Gel Forming Formulations , 2020, bioRxiv.

[13]  B. Medhi,et al.  Possible prophylactic or preventive role of topical povidone iodine during accidental ocular exposure to 2019-nCoV , 2020, Graefe's Archive for Clinical and Experimental Ophthalmology.

[14]  V. Jhanji,et al.  Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea , 2020, Eye.

[15]  R. Horres,et al.  Expression of the COVID‐19 receptor ACE2 in the human conjunctiva , 2020, Journal of medical virology.

[16]  M. Eisenhut,et al.  Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view , 2020, Autoimmunity Reviews.

[17]  H. Mack,et al.  Management of conjunctivitis during the COVID-19 pandemic 2020. , 2020, Australian journal of general practice.

[18]  Huatao Xie,et al.  SARS-CoV-2 in the ocular surface of COVID-19 patients , 2020, Eye and Vision.

[19]  C. Snyderman,et al.  Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as “Personal Protective Equipment” for frontline providers exposed in high-risk head and neck and skull base oncology care , 2020, Oral Oncology.

[20]  Weiyong Liu,et al.  The evidence of SARS-CoV-2 infection on ocular surface , 2020, The Ocular Surface.

[21]  Ting Huang,et al.  Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease , 2020, British Journal of Ophthalmology.

[22]  Kaili Wu,et al.  Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China , 2020, JAMA ophthalmology.

[23]  B. Medhi,et al.  Ocular Manifestations and Tear or Conjunctival Swab PCR Positivity for 2019-nCoV in Patients with COVID-19: A Systematic Review and Meta-Analysis , 2020, SSRN Electronic Journal.

[24]  Zhe Liu,et al.  Role of the Eye in Transmitting Human Coronavirus: What We Know and What We Do Not Know , 2020, Frontiers in Public Health.

[25]  H. Gao,et al.  Rhesus macaques can be effectively infected with SARS-CoV-2 via ocular conjunctival route , 2020, bioRxiv.

[26]  D. Wang,et al.  The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status , 2020, Military Medical Research.

[27]  Ajay Prakash,et al.  Update on the target structures of SARS-CoV-2: A systematic review , 2020, Indian journal of pharmacology.

[28]  Cheng-wei Lu,et al.  2019-nCoV transmission through the ocular surface must not be ignored , 2020, The Lancet.

[29]  B. Medhi,et al.  Drug targets for corona virus: A systematic review , 2020, Indian journal of pharmacology.

[30]  M. Eickmann,et al.  In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens , 2018, Infectious Diseases and Therapy.

[31]  R. Einspanier,et al.  mRNA expression pattern of selected candidate genes differs in bovine oviductal epithelial cells in vitro compared with the in vivo state and during cell culture passages , 2016, Reproductive Biology and Endocrinology.

[32]  M. Zaitseva,et al.  In vitro culture significantly alters gene expression profiles and reduces differences between myometrial and fibroid smooth muscle cells. , 2006, Molecular human reproduction.

[33]  S. Teoh,et al.  The severe acute respiratory syndrome coronavirus in tears , 2004, British Journal of Ophthalmology.

[34]  D. Freitas,et al.  Corneal Toxicity of Povidone-Iodine Eye Drops , 2002 .